SPHERIX INC (37)

Browse by Contract Category

Contracts

Amendment to Employment Agreement, dated as of January 1, 2023, by and between Dominari Holdings Inc. and Christopher Devall (Filed With SEC on January 6, 2023)
Amendment to Amended and Restated Services Agreement, dated October 19, 2022, by and between Dominari Financial Inc. and Kyle Wool (Filed With SEC on October 21, 2022)
Membership Interest Purchase Agreement, by and among Dominari Financial Inc., Fieldpoint Private Securities, LLC and Fieldpoint Private Bank & Trust (Filed With SEC on September 12, 2022)
Exclusive Patent License Agreement by and among Silo Pharma Inc., a Delaware corporation and Silo Pharma Inc., a Florida corporation, and their affiliates/subsidiaries... (Filed With SEC on April 16, 2021)
Engagement Agreement, dated January 24, 2020, as amended on March 2, 2020, between AIkido Pharma Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 26, 2020)
Employment Agreement, made and entered into as of July 1, 2022, by and between Aikido Pharma Inc and Chris Devall (Filed With SEC on January 6, 2023)
Amended and Restated Services Agreement, effective as of October 17, 2022, by and between Dominari Financial Inc. and Kyle Wool (Filed With SEC on October 21, 2022)
Confirmation of Mutual Understanding, dated March 24, 2022 (Filed With SEC on March 28, 2022)
Form of Securities Purchase Agreement between Aikido Pharma Inc. and the investors therein, dated February 24, 2022 (Filed With SEC on March 2, 2022)
Amendment No. 3 to the Employment Agreement with Anthony Hayes, dated June 28, 2021 (Filed With SEC on July 2, 2021)
Amendment to Exclusive Patent License Agreement, dated April 12, 2021 (Filed With SEC on April 16, 2021)
Form of Underwriters Warrant (Filed With SEC on February 18, 2021)
Amended and Restated Underwriting Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated February 16, 2021 (Filed With SEC on February 18, 2021)
Convertible Promissory Note dated January 29, 2021 (Filed With SEC on February 3, 2021)
Securities Purchase Agreement by and between Convergent Therapeutics, Inc. and the Company, dated January 29, 2021 (Filed With SEC on February 3, 2021)
Form of Placement Agents Warrant (Filed With SEC on April 15, 2020)
Form of Securities Purchase Agreement (Filed With SEC on April 15, 2020)
Rights Agreement, dated as of March 23, 2020, by and between AIkido Pharma Inc., as the Company, and VStock Transfer, LLC, as Rights Agent (Filed With SEC on March 25, 2020)
Form of Placement Agents Warrant (Filed With SEC on March 10, 2020)
Form of Securities Purchase Agreement (Filed With SEC on March 10, 2020)
Form of Pre-Funded Warrant (Filed With SEC on February 28, 2020)
Form of Placement Agent Warrant (Filed With SEC on February 28, 2020)
Form of Common Warrant (Filed With SEC on February 28, 2020)
Form of Securities Purchase Agreement (Filed With SEC on February 28, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among Wake Forest University Health Sciences, CBM BioPharma, Inc. and Spherix Incorporated (Filed With SEC on February 3, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among The University of Texas in Austin, on behalf of the Board of Regents of the University of Texas, CBM... (Filed With SEC on February 3, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among The University of Texas in Austin, on behalf of the Board of Regents of the University of Texas, CBM... (Filed With SEC on January 31, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among Wake Forrest University Health Sciences, CBM BioPharma, Inc. and Spherix Incorporated (Filed With SEC on January 31, 2020)
Amendment No. 2 to Asset Purchase Agreement, dated as of December 5, 2019, by and between the Company and CBM BioPharma, Inc (Filed With SEC on December 10, 2019)
At The Market Offering Agreement, dated August 9, 2019, by and between Spherix Incorporated and H.C. Wainwright & Co., LLC (Filed With SEC on August 12, 2019)
Form of Amendment to Securities Purchase Agreement, dated June 6, 2019, by and between the Company and the purchaser party thereto (Filed With SEC on June 7, 2019)
Form of Warrant (Filed With SEC on June 7, 2019)
Amendment No. 1 to Asset Purchase Agreement, dated May 30, 2019, by and between the Company and CBM BioPharma, Inc (Filed With SEC on May 31, 2019)
Form of Securities Purchase Agreement, dated May 29, 2019, by and between the Company and the purchaser party thereto (Filed With SEC on May 31, 2019)
Form of Warrant (Filed With SEC on May 31, 2019)
Form of Share Purchase Agreement, dated May 15, 2019, by and between Spherix Incorporated and the sellers signatory thereto (Filed With SEC on May 15, 2019)
Asset Purchase Agreement, dated May 15, 2019, by and between Spherix Incorporated and CBM Biopharma, Inc (Filed With SEC on May 15, 2019)